We used the Genomics of Drug Sensitivity in Cancer database to evaluate the inhibitory effect of BRD4-targeted drug PFI-1 and (BRD2, BRD3, and BRD4)-targeted drug I-BET-151 on ACC cell lines. Here, BRD4 is linked to cancer.